CPLX2 encodes a protein involved in neurotransmitter release whilst GRIA1 encodes an excitatory glutamate (AMPA) receptor and deficiencies in the expression of each have been detected in the AD brain (Ramos-Miguel et al., 2017; Williams et al., 2021). This evidence concerns the gene GRIA1 and Alzheimer disease.